| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.34 | 6e-18 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-10 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-09 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-08 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-07 |